CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production
/
DateAug 05 2025
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) — Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced... Read More →

















